ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
New York Times Examines Pharmaceutical Lobby, Effect On States
The New York Times on Tuesday examined how pharmaceutical lobbyists are active in all 50 states because "the industry knows that controlling drug costs is a subject with nearly universal popular appeal." All state legislatures have weighed legislation involving pharmaceuticals, and last year state lawmakers considered more than 600 bills that address prescription drugs. Some proposals were pro-industry, including measures to protect manufacturers from product liability claims and to expand access to brand-name drugs, but "several states have passed laws that represent a barely perceptible shift toward regulation" of drug costs, the Times reports. This trend "elicits fear and loathing" from the pharmaceutical industry, which asserts that "such control would stifle the innovation needed to develop life-saving drugs," according to the Times. The pharmaceutical industry has successfully opposed many of the strongest state measures, including California's Proposition 79, which would have compelled drug companies to finance discounts to the uninsured. The Times profiles lobbying efforts in West Virginia, where "a relatively old, poor and sick population means high health spending." The Pharmaceutical Research and Manufacturers of America has nine registered lobbyists in the state, and 24 lobbyists there are employed by individual drug companies. Lobbying activities are particularly focused on a proposed regulation that would require drug makers to disclose details of their marketing activity in the state, including expenses, the number of sales people and gifts given to doctors. Ken Johnson, senior vice president of PhRMA, said, "We're going to continue to aggressively try to defeat what we consider bad legislation" (Saul, New York Times, 1/31).
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
New York Times analizeazã farmaceutice de lobby, efectul asupra membre - New York Times Examines Pharmaceutical Lobby, Effect On States - articole medicale engleza - startsanatate
